Tag: chemistry
-
Peptide Discovery Company to Gain $3.3B in Licensing Deals
A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion.
-
Food Protein Biotech Adds €4M in Seed Funds
A new company creating protein ingredients for food products from carbon dioxide converted by engineered bacteria is raising €4 million more in seed funds.
-
Cell Biology Tools Companies Merge in $57.8M Deal
Two providers of technologies for cellular analysis are merging to form a new company focusing on cell biology research tools, in a sign of continued industry consolidation.
-
Trial Shows Gel Clears Common Skin Cancer Wounds
Results of a clinical trial indicate a gel applied to lesions caused by basal cell carcinoma is safe for patients and clears the cancerous skin tumors.
-
Trial Shows Fast-Absorbing Opioid Overdose Nasal Swab
Results of a clinical trial show a nasal swab dispensing an opioid antidote transfers more of the antidote into the blood stream than syringe injections or nasal sprays.
-
Sustained-Released Eye Treatment Company Raises $11.9M
A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round.
-
Trial Shows Insulin Capsules Reduce Blood Glucose Levels
Results of a clinical trial reveal an optimal dose for an insulin capsule that in 12 weeks reduces blood glucose levels in patients with type 2 diabetes.
-
Biomarker-Guided Depression Drug Trial Underway
The first participant in a clinical trial received an experimental drug to treat patients with depression that express high levels of a stress-related protein.
-
Biotech, Regeneron in $2B Cancer Antibody Deal
A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies.
-
Biotech, M.D. Anderson Partner on Precision Drug Design
A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines.